- Home
- SMJF vs ALGS Comparison
SMJF vs ALGS Comparison
Compare SMJF & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMJF | ALGS |
|---|---|---|
| Founded | 1988 | 2018 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.5M | 34.6M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SMJF | ALGS |
|---|---|---|
| Price | $1.05 | $5.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | ★ 1.5M | 46.9K |
| Earning Date | 09-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,186,000.00 |
| Revenue This Year | N/A | $32.20 |
| Revenue Next Year | N/A | $4.71 |
| P/E Ratio | $68.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.82 | $3.98 |
| 52 Week High | $11.48 | $13.69 |
Technical Indicators
Market Signals| Indicator | SMJF | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 23.09 | 38.54 |
| Support Level | $0.90 | $4.80 |
| Resistance Level | $3.70 | $6.91 |
| Average True Range (ATR) | 0.07 | 0.44 |
| MACD | -0.05 | -0.14 |
| Stochastic Oscillator | 33.33 | 14.68 |
Price Performance
Historical ComparisonAbout SMJF SMJ International Holdings Inc. Class A Ordinary Shares
SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, polypropylene tiles, broadloom carpets, and vinyl tiles. It operates under the proprietary brand 'SMJ'. The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. Geographically, it has a presence across Malaysia, Indonesia, the Philippines, Vietnam, India, Singapore, and other markets. The company generates revenue mainly through the sale and distribution of its flooring products, prominently in Singapore.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.